Top Markets
Coin of the day
Lunai Bioworks Inc. Lunai Bioworks Inc.

Lunai Bioworks Inc.

LNAI
Rank in Stocks #32427
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to... Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Share Price
$2.24
Last synced: 2026-08-17
Market Cap
$10.13M
Change (1 day)
0.68%
Change (1 year)
-
Country
US
Trade Lunai Bioworks Inc. (LNAI)

Category

Operating Margin for Lunai Bioworks Inc. (LNAI)
Operating Margin as of 2026 TTM: 0.00%
According to Lunai Bioworks Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Lunai Bioworks Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.